The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Lyme Disease Testing by Large Commercial Laboratories in the United States
Open accessAbstract
Large commercial laboratories in the United States were surveyed to determine Lyme disease testing frequency, practices, and results. Approximately 3.4 million tests were conducted in 2008; 62% in accordance with recommendations. We estimate that 288 000 infections occurred among 2.4 million patients from whom samples were submitted. Background. Laboratory testing is helpful when evaluating patients with suspected Lyme disease (LD). A 2-tiered antibody testing approach is recommended, but single-tier and nonvalidated tests are also used. We conducted a survey of large commercial laboratories in the United States to assess laboratory practices. We used these data to estimate the cost of testing and number of infections among patients from whom specimens were submitted. Methods. Large commercial laboratories were asked to report the type and volume of testing conducted nationwide in 2008, as well as the percentage of positive tests for 4 LD-endemic states. The total direct cost of testing was calculated for each test type. These data and test-specific performance parameters available in published literature were used to estimate the number of infections among source patients. Results. Seven participating laboratories performed approximately 3.4 million LD tests on approximately 2.4 million specimens nationwide at an estimated cost of $492 million. Two-tiered testing accounted for at least 62% of assays performed; alternative testing accounted for <3% of assays. The estimated frequency of infection among patients from whom specimens were submitted ranged from 10% to 18.5%. Applied to the total numbers of specimens, this yielded an estimated 240 000 to 444 000 infected source patients in 2008. Discussion. LD testing is common and costly, with most testing in accordance with diagnostic recommendations. These results highlight the importance of considering clinical and exposure history when interpreting laboratory results for diagnostic and surveillance purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Summary of notifiable diseases--United States, 2012.
Adams, D. A., Jajosky, R. A., Ajani, U. A., Kriseman, J., Sharp, P., Onwen, D. H., Schley, A. W., Anderson, W. J., Grigoryan, A., Aranas, A. E., et al. (2014) · PubMed · Cited by 1,342
Summary of notifiable diseases--United States, 2002.
Groseclose, S. L., Brathwaite, W. S., Hall, P. A., Connor, F. J., Sharp, P., Anderson, W. J., Fagan, R. F., Javier, A. J., Jones, G. F., Nitschke, D. A., et al. (2004) · PubMed · Cited by 1,338
Steere, A. C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908313210906 · Cited by 1,192
The Clinical Evolution of Lyme Arthritis
STEERE, A. C., SCHOEN, R. T., & TAYLOR, E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-5-725 · Cited by 784
Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I., & Wormser, G. P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.484-509.2005 · Cited by 744
Western Blotting in the Serodiagnosis of Lyme Disease
Dressler, F., Whalen, J. A., Reinhardt, B. N., & Steere, A. C. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.392 · Cited by 694
Erythema Chronicum Migrans and Lyme Arthritis: The Enlarging Clinical Spectrum
STEERE, A. C., MALAWISTA, S. E., HARDIN, J. A., RUDDY, S., ASKENASE, P. W., & ANDIMAN, W. A. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-6-685 · Cited by 681
The Early Clinical Manifestations of Lyme Disease
STEERE, A. C., BARTENHAGEN, N. H., CRAFT, J. E., HUTCHINSON, G. J., NEWMAN, J. H., RAHN, D. W., SIGAL, L. H., SPIELER, P. N., STENN, K. S., & MALAWISTA, S. E. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-1-76 · Cited by 662
(1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530120023018 · Cited by 590
Chronic Neurologic Manifestations of Lyme Disease
Logigian, E. L., Kaplan, R. F., & Steere, A. C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011223232102 · Cited by 536
Summary of notifiable diseases--United States, 2006.
McNabb, S. J. N., Jajosky, R. A., Hall-Baker, P. A., Adams, D. A., Sharp, P., Worshams, C. A., Anderson, W. J., Javier, A. J., Jones, G. J., Nitschke, D. A., et al. (2008) · PubMed · Cited by 447
The Overdiagnosis of Lyme Disease
Steere, A. C. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500140064037 · Cited by 354
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
Engstrom, S. M., Shoop, E., & Johnson, R. C. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.2.419-427.1995 · Cited by 338
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., HALPERIN, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J., Strle, F., Stanek, G., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/522848 · Cited by 302
Bacon, R. M., Biggerstaff, B. J., Schriefer, M. E., Gilmore, Jr., Philipp, M. T., Steere, A. C., Wormser, G. P., Marques, A. R., & Johnson, B. J. B. (2003) · The Journal of Infectious Diseases · doi:10.1086/374395 · Cited by 290
Self-citationLaboratory Evaluation in the Diagnosis of Lyme Disease
Tugwell, P., Dennis, D. T., Weinstein, A., Wells, G., Shea, B., Nichol, G., Hayward, R., Lightfoot, R., Baker, P., & Steere, A. C. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-12-199712150-00011 · Cited by 264
Lyme neuroborreliosis: Central nervous system manifestations
Halperin, J. J., Luft, B. J., Anand, A. K., Roque, C. T., Alvarez, O., Volkman, D. J., & Dattwyler, R. J. (1989) · Neurology · doi:10.1212/wnl.39.6.753 · Cited by 263
Appropriate Use of Screening and Diagnostic Tests to Foster High-Value, Cost-Conscious Care
Qaseem, A., Alguire, P., Dallas, P., Feinberg, L. E., Fitzgerald, F. T., Horwitch, C., Humphrey, L., LeBlond, R., Moyer, D., Wiese, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-2-201201170-00011 · Cited by 243
Branda, J. A., Linskey, K., Kim, Y. A., Steere, A. C., & Ferraro, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir464 · Cited by 164
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease
Wormser, G. P., Schriefer, M., Aguero-Rosenfeld, M. E., Levin, A., Steere, A. C., Nadelman, R. B., Nowakowski, J., Marques, A., Johnson, B. J. B., & Dumler, J. S. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.09.003 · Cited by 160
Self-citationSummary of notifiable diseases -- United States, 2010
Adams, D. A., Gallagher, K., Jajosky, R. A., Ward, J., Sharp, P., Anderson, W. J., Abellera, J. P., Aranas, A. E., Mayes, M., Wodajo, M. S., et al. (2012) · Cited by 133
Branda, J. A., Aguero‐Rosenfeld, M. E., Ferraro, M. J., Johnson, B. J. B., Wormser, G. P., & Steere, A. C. (2009) · Clinical Infectious Diseases · doi:10.1086/648674 · Cited by 102
Self-citationLaboratory testing for suspected lyme disease
Bunikis, J., & Barbour, A. G. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00089-0 · Cited by 94
Biliary Complications in the Treatment of Unsubstantiated Lyme Disease
Ettestad, P. J., Campbell, G. L., Welbel, S. F., Genese, C. A., Spitalny, K. C., Marchetti, C. M., & Dennis, D. T. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.356 · Cited by 84
Orioski, K. A., Campbell, G. L., Genese, C. A., Beckley, J. W., Schriefer, M. E., Spitalny, K. C., & Dennis, D. T. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009462 · Cited by 82
Wormser, G. P., Levin, A. E., Soman, S., Adenikinju, O., Longo, M. V., & Branda, J. A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01853-13 · Cited by 58
Naleway, A. L., Belongia, E. A., Kazmierczak, J. J., Greenlee, R. T., & Davis, J. P. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.12.1120 · Cited by 51
Summary of notifiable diseases: United States, 2009.
(2011) · PubMed · Cited by 48
The VlsE (IR6) Peptide ELISA in the Serodiagnosis of Lyme Facial Paralysis
Peltomaa, M., McHugh, G., & Steere, A. C. (2004) · Otology & Neurotology · doi:10.1097/00129492-200409000-00031 · Cited by 31
Appropriateness of Lyme Disease Serologic Testing
Ramsey, A. (2004) · The Annals of Family Medicine · doi:10.1370/afm.117 · Cited by 25
Cited by
Surveillance for Lyme Disease — United States, 2008–2015
Schwartz, A. M., Hinckley, A. F., Mead, P. S., Hook, S. A., & Kugeler, K. J. (2017) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6622a1 · Cited by 885
Self-citationSteere, A. C., Strle, F., Wormser, G. P., Hu, L. T., Branda, J. A., Hovius, J. W. R., Li, X., & Mead, P. S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.90 · Cited by 845
Self-citationVital Signs: Trends in Reported Vectorborne Disease Cases — United States and Territories, 2004–2016
Rosenberg, R., Lindsey, N. P., Fischer, M., Gregory, C. J., Hinckley, A. F., Mead, P. S., Paz-Bailey, G., Waterman, S. H., Drexler, N. A., Kersh, G. J., et al. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6717e1 · Cited by 821
Self-citationEisen, R. J., Eisen, L., & Beard, C. B. (2016) · Journal of Medical Entomology · doi:10.1093/jme/tjv237 · Cited by 414
Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010
Nelson, C. A., Saha, S., Kugeler, K. J., Delorey, M. J., Shankar, M. B., Hinckley, A. F., & Mead, P. S. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2109.150417 · Cited by 396
Self-citation
Metadata
- Authors
- Hinckley, A. F., Connally, N. P., Meek, J. I., Johnson, B. J., Kemperman, M. M., Feldman, K. A., White, J. L., & Mead, P. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-30
- Volume
- 59
- Issue
- 5
- Pages
- 676-681
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126969588
- Cited by
- 386
- References
- 31
- FWCI
- 28.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.